-
NeuroVasx Receives FDA Approval for cPAX Aneurysm Treatment System
MAPLE GROVE, Minn., April 5, 2011– NeuroVasx announced today that the FDA has approved the cPAX Aneurysm Treatment System as a Humanitarian Use Device (HDE) for the treatment of large, giant and wide-neck cerebral aneurysms, which are typically the most difficult to treat. The HDE allows for the treatment of up to 4,000 patients per […]
Posted on Thursday, April 7, 2011Read More